ABSTRACT
In situ forming implants (ISIs) based on poly(lactic acid-co-glycolic acid) (PLGA) containing leuprolide acetate/β-cyclodextrin (LA/β-CD) complexes were prepared. Incorporation of LA or complexes did not change Tg values of ISIs (48.4–49.6°C). ISIs containing complexes with more β-CD content showed higher surface and bulk porosity. Higher β-CD portion in complexes improved solvent release, decreased initial burst release and facilitated diffusion out of drug for corresponding ISIs. Complexation of LA with β-CD (1/10, w/w) significantly improved its stability within PLGA matrix before release (total LA release of 91.3%). ISIs did not show any cellular cytotoxic effects against L929 fibroblast cells.
GRAPHICAL ABSTRACT
![](/cms/asset/652e92a1-c343-4c18-b976-3a20a8a0480b/gpom_a_1055633_uf0001_oc.jpg)